Relapsing Multiple Sclerosis (RMS) Recruiting Phase 1 Trials for Cladribine (DB00242)

Also known as: Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare

IndicationStatusPhase
DBCOND0044896 (Relapsing Multiple Sclerosis (RMS))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03745144Effects of Cladribine Tablets on the Pharmacokinetics of Microgynon®Other
NCT04086225Effects of Cladribine Tablets on the Pharmacokinetics of Microgynon®Other